Johanna Kuhlin

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CLINICAL INFECTIOUS DISEASES. 2021;73(9):e3511-e3517
Genotypic Resistance of Pyrazinamide but Not Minimum Inhibitory Concentration Is Associated With Longer Time to Sputum Culture Conversion in Patients With Multidrug-resistant Tuberculosis
Kuhlin J; Forsman LD; Mansjo M; Nordvall MJ; Wijkander M; Wagrell C; Jonsson J; Groenheit R; Werngren J; Schon T; Bruchfeld J
Article: EUROPEAN RESPIRATORY JOURNAL. 2021;57(3):2003463
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China.
Davies Forsman L; Niward K; Kuhlin J; Zheng X; Zheng R; Ke R; Hong C; Werngren J; Paues J; Simonsson USH; Eliasson E; Hoffner S; Xu B; Alffenaar J-W; Schön T; Hu Y; Bruchfeld J
Article: JOURNAL OF CHROMATOGRAPHY B: ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. 2020;1158:122397
Development and validation of a simple LC-MS/MS method for simultaneous determination of moxifloxacin, levofloxacin, prothionamide, pyrazinamide and ethambutol in human plasma
Zheng X; Jongedijk EM; Hu Y; Kuhlin J; Zheng R; Niward K; Paues J; Xu B; Forsman LD; Schon T; Bruchfeld J; Alffenaar J-WC
Article: LAKARTIDNINGEN. 2020;117:20039
[Is it time to use sputum induction as a complementary specimen collection procedure in adult patients with suspected pulmonary tuberculosis?].
Kuhlin J; Tammelin A; Petersson J; Chryssanthou E; Tideholm-Nylén A; Schön T; Bruchfeld J
Article: BMJ OPEN. 2020;10(6):e035350
Prospective evaluation of improving fluoroquinolone exposure using centralised therapeutic drug monitoring (TDM) in patients with tuberculosis (PERFECT): a study protocol of a prospective multicentre cohort study
van den Elsen SHJ; Sturkenboom MGG; Akkerman O; Barkane L; Bruchfeld J; Eather G; Heysell SK; Hurevich H; Kuksa L; Kunst H; Kuhlin J; Manika K; Moschos C; Mpagama SG; Munoz Torrico M; Skrahina A; Sotgiu G; Tadolini M; Tiberi S; Volpato F; van der Werf TS; Wilson MR; Zuniga J; Touw DJ; Migliori GB; Alffenaar J-W
Article: BMJ OPEN. 2018;8(9):e023899
Plasma concentrations of second-line antituberculosis drugs in relation to minimum inhibitory concentrations in multidrug-resistant tuberculosis patients in China: a study protocol of a prospective observational cohort study
Forsman LD; Niward K; Hu Y; Zheng R; Zheng X; Ke R; Cai W; Hong C; Li Y; Gao Y; Werngren J; Paues J; Kuhlin J; Simonsson USH; Eliasson E; Alffenaar J-W; Mansjo M; Hoffner S; Xu B; Schon T; Bruchfeld J
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2018;22(5):544-550
Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan
Kuhlin J; Smith C; Khaemraev A; Tigay Z; Parpieva N; Tillyashaykhov M; Achar J; Hajek J; Greig J; du Cros P; Moore D

Alla övriga publikationer

Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2023;62(3):106914
Is there a need to optimise pyrazinamide doses in patients with tuberculosis? A systematic review
Chen RH; Michael T; Kuhlin J; Schon T; Stocker S; Alffenaar J-WC
Thesis / dissertation: 2023
Treatment optimisation of multidrug-resistant tuberculosis
Kuhlin, Johanna
Corrigendum: JOURNAL OF MASS SPECTROMETRY AND ADVANCES IN THE CLINICAL LAB. 2022;25:72
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45]
Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; Van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar J-WC
Review: CLINICAL MASS SPECTROMETRY. 2019;14:34-45
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs
Kuhlin J; Sturkenboom MGG; Ghimire S; Margineanu I; van den Elsen SHJ; Simbar N; Akkerman OW; Jongedijk EM; Koster RA; Bruchfeld J; Touw DJ; Alffenaar J-WC

Anställningar

Anknuten till Forskning, Medicin, Solna, Karolinska Institutet, 2022-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2023
Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2023

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI